Chi-Tai Yeh

Title: Innovations by Chi-Tai Yeh

Introduction

Chi-Tai Yeh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative methods and research. With a total of four patents to his name, Yeh's work focuses on enhancing immunotherapy and addressing challenges in cancer treatment.

Latest Patents

Chi-Tai Yeh's latest patents include a method for enhancing the effect of immunotherapy for cancer. This method involves administering an effective amount of a polysaccharide extract to improve the therapeutic outcomes for patients. Additionally, he has developed a method for increasing a subject's pool of M1 macrophages, particularly for those suffering from conditions associated with undesirable M2 macrophage activation. Another notable patent is the method of using antimycin A to downregulate the Wnt/b-catenin pathway, which aims to treat gefitinib-resistant cancers. This method specifically targets the growth of cancer stem cells, including those associated with colorectal, liver, lung, and breast cancers.

Career Highlights

Throughout his career, Chi-Tai Yeh has worked with various organizations, contributing to advancements in medical research and treatment methodologies. His innovative approaches have garnered attention in the scientific community, particularly in the realm of cancer therapies.

Collaborations

Chi-Tai Yeh has collaborated with notable professionals in his field, including Yew-Min Tzeng and Chun-Hung Wu. These collaborations have further enriched his research and development efforts.

Conclusion

Chi-Tai Yeh's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and therapy.